Rheinmetall's December Pivot: A €12.4 Billion Boxer Decision Looms Over a Halved Share Price

Rheinmetall shares fall 2.1% to €1,068.80 amid analyst divergence; MWB upgrades to Hold, Deutsche Bank keeps Buy. Key Arminius decision Dec 9.

The disconnect has rarely been starker. Rheinmetall keeps stacking operational wins — a prototype handed to the U.S. Army, fresh orders from a Norwegian defence partner, drone approvals in Germany — while its stock keeps sliding. On Wednesday, the shares led the DAX's losers with a 3.31 percent drop, slipping below key moving averages, and the weakness has extended into Thursday, with the equity trading around 1,068.80 euros, down roughly 2.1 percent on the day.

Analysts are struggling to keep pace with the whipsaw. MWB Research, which downgraded Rheinmetall to "Sell" as recently as early August — citing a halved investment ratio and a trimmed backlog target — has now reversed course, lifting its rating to "Hold" while leaving its price objective untouched at 1,050 euros. The rationale: market pricing of risks to revenue expectations has improved. Deutsche Bank, by contrast, reaffirmed a "Buy" recommendation on Tuesday with a target of 1,800 euros, underscoring just how wide the gulf between professional assessments has become.

The December Catalyst

MWB's upgrade carries a specific hook: an anticipated improvement in the news flow toward month-end, centred on the Bundeswehr's "Arminius" programme. The project involves a major order for Boxer wheeled vehicle variants, with the Bundestag slated to take it up on December 9. A fixed contract worth roughly 12.4 billion euros could be signed five to ten days later. CEO Armin Papperger has also flagged a service agreement with a total volume of 4 billion euros, of which 2 billion would accrue to Rheinmetall. Two additional options could push the overall framework to approximately 26 billion euros.

The timing matters. Rheinmetall has already had to walk back part of its 2025 guidance, trimming it by 300 million euros to a range of 13.7 to 14.2 billion euros after being dropped from the F126 frigate project. Organic growth is still expected to land between 28 and 31 percent, but the revision has fed a broader narrative of recalibration across the defence sector after years of extraordinary gains.

A Steady Stream of Deliveries

Operationally, the cadence of announcements shows no sign of letting up. American Rheinmetall has delivered the first of eight Lynx XM30 prototype vehicles to the U.S. Army — a programme designed to eventually replace the M2 Bradley infantry fighting vehicle. The same day, the U.S. subsidiary disclosed a roughly 710,000-dollar order from Kongsberg Defence & Aerospace for machined MCT-30 turret components tied to the USMC ACV-30 programme, with production running in Lapeer and Lansing, Michigan, and deliveries slated through 2026 and 2027.

The Kongsberg contract is modest in isolation, but it reinforces a broader pattern: Rheinmetall is embedding itself as a multi-programme supplier across U.S. defence procurement rather than chasing one-off wins. In Europe, the Bundeswehr's aviation authority granted preliminary airworthiness certification for the LUNA NG reconnaissance drone on Tuesday, and late August brought a first order for a modular camp in Lithuania under the Contractor Augmentation Program II. That followed a Bundeswehr award exceeding 500 million euros for mobile medical stations, lifting the total order to 165 systems worth over 600 million euros.

The Numbers Beneath the Noise

Second-quarter results support the view that the underlying business remains sturdy. Revenue climbed roughly 69 to 70 percent to 3.289 billion euros, while operating profit more than doubled to 562 million euros, translating into a 17.1 percent margin. The order book expanded 44 percent to surpass 80 billion euros, buoyed by a 6-billion-euro package from Romania alongside the 12.4-billion-euro vehicle contract.

None of that has shielded the stock from a brutal correction. From a 52-week high of 2,007.00 euros on October 3, the shares have shed nearly half their value. The slide appears driven less by any single corporate event than by profit-taking and technical factors following a sustained run — a market-wide reassessment of defence valuations rather than a verdict on Rheinmetall's execution.

A Calendar Worth Watching

For investors, the near-term script is unusually clear. The Bundestag's December 9 session on Arminius, followed by a possible contract signing, represents the most tangible potential catalyst on the horizon. Rheinmetall's management will also address investors at Morgan Stanley's "Industrial CEOs unplugged" conference on September 8, offering an opportunity to frame the current juncture. Whether the market chooses to reward the operational drumbeat — or continues to demand a discount for political and budgetary uncertainty — may well hinge on how those dates play out.